Detalles de la búsqueda
1.
Distinct profiles of proliferating CD8+/TCF1+ T cells and CD163+/PD-L1+ macrophages predict risk of relapse differently among treatment-naïve breast cancer subtypes.
Cancer Immunol Immunother
; 73(3): 46, 2024 Feb 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38349444
2.
Comparison of breast fine-needle aspiration cytology and tissue sampling for high-throughput proteomic analysis and cancer biomarker detection.
Pathobiology
; 2024 May 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38815563
3.
Diagnostic Challenges during Inflammation and Cancer: Current Biomarkers and Future Perspectives in Navigating through the Minefield of Reactive versus Dysplastic and Cancerous Lesions in the Digestive System.
Int J Mol Sci
; 25(2)2024 Jan 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38279253
4.
HER2 amplification level by in situ hybridization predicts survival outcome in advanced HER2-positive breast cancer treated with pertuzumab, trastuzumab, and docetaxel regardless of HER2 IHC results.
Breast Cancer Res
; 25(1): 154, 2023 12 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38098054
5.
The prognostic value of a combined immune score in tumor and immune cells assessed by immunohistochemistry in triple-negative breast cancer.
Breast Cancer Res
; 25(1): 134, 2023 11 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37924153
6.
Quantitative proteomics identifies TUBB6 as a biomarker of muscle-invasion and poor prognosis in bladder cancer.
Int J Cancer
; 152(2): 320-330, 2023 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36054443
7.
Proteomics analysis of an individual formalin-fixed paraffin-embedded tissue section using isobaric-tag amplification.
Rapid Commun Mass Spectrom
; 37(22): e9616, 2023 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37817342
8.
Discrepancies in Hormone Receptor and HER2 Expression between Malignant Serous Effusions and Paired Tissues from Primary or Recurrent Breast Cancers.
Pathobiology
; 2023 Oct 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37816333
9.
Prognostic role of tumor subtype and germline BRCA mutation in advanced breast cancer patients treated with palbociclib plus endocrine therapy.
Breast Cancer Res Treat
; 196(1): 121-128, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36070058
10.
Diffusion-weighted Breast MRI in Prediction of Upstaging in Women with Biopsy-proven Ductal Carcinoma in Situ.
Radiology
; 305(2): 307-316, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35787199
11.
HER2 expression, copy number variation and survival outcomes in HER2-low non-metastatic breast cancer: an international multicentre cohort study and TCGA-METABRIC analysis.
BMC Med
; 20(1): 105, 2022 03 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-35296300
12.
Artificial intelligence system shows performance at the level of uropathologists for the detection and grading of prostate cancer in core needle biopsy: an independent external validation study.
Mod Pathol
; 35(10): 1449-1457, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35487950
13.
Dual Oxidase 2 (DUOX2) as a Proteomic Biomarker for Predicting Treatment Response to Chemoradiation Therapy for Locally Advanced Rectal Cancer: Using High-Throughput Proteomic Analysis and Machine Learning Algorithm.
Int J Mol Sci
; 23(21)2022 Oct 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-36361712
14.
Discovery of Proteins Responsible for Resistance to Three Chemotherapy Drugs in Breast Cancer Cells Using Proteomics and Bioinformatics Analysis.
Molecules
; 27(6)2022 Mar 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35335125
15.
Quantitative Proteomics Reveals Knockdown of CD44 Promotes Proliferation and Migration in Claudin-Low MDA-MB-231 and Hs 578T Breast Cancer Cell Lines.
J Proteome Res
; 20(7): 3720-3733, 2021 07 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34075748
16.
Glandular Tissue Component and Breast Cancer Risk in Mammographically Dense Breasts at Screening Breast US.
Radiology
; 301(1): 57-65, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34282967
17.
Genomic profile of metastatic breast cancer patient-derived xenografts established using percutaneous biopsy.
J Transl Med
; 19(1): 7, 2021 01 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33407601
18.
Parallel Reaction Monitoring-Mass Spectrometry (PRM-MS)-Based Targeted Proteomic Surrogates for Intrinsic Subtypes in Breast Cancer: Comparative Analysis with Immunohistochemical Phenotypes.
J Proteome Res
; 19(7): 2643-2653, 2020 07 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31755719
19.
Combined the SMAC mimetic and BCL2 inhibitor sensitizes neoadjuvant chemotherapy by targeting necrosome complexes in tyrosine aminoacyl-tRNA synthase-positive breast cancer.
Breast Cancer Res
; 22(1): 130, 2020 11 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-33239070
20.
Prediction of pathologic complete response using image-guided biopsy after neoadjuvant chemotherapy in breast cancer patients selected based on MRI findings: a prospective feasibility trial.
Breast Cancer Res Treat
; 182(1): 97-105, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32418044